Zhang Xiaojin
Pharmaceutical Chemistry
China Pharmaceutical University
China
Biography
Zhang Xiaoyin, male, born in 1986 , Ph.D. in pharmaceutical chemistry, associate professor, doctoral tutor, Jiangsu province drug design and optimization key laboratory member. In 2007 , he graduated from the Pharmaceutical Engineering of China Pharmaceutical University. He received his Ph.D. degree in Pharmaceutical Chemistry from China Pharmaceutical University in 2012. He was admitted to the Faculty of Organic Chemistry in the same year and was promoted to Associate Professor in 2015 . At present the National Natural Science Foundation of Youth Project 1 item Natural Science Foundation of Jiangsu Province youth project 1 , participate in the National Natural Science Fund Project 1 items. In recent years, with the first or corresponding author of Medicinal Chemistry Journal , Organic Letters , European Journal of Medicinal Chemistry internationally renowned journals and other professional fields published SCI papers nearly 20 Pian; in the preparation of monographs 1 Bu; patent 5 , has authorized Patent 1 item.
Research Interest
Drug design and synthesis for cancer and blood diseases; structural modification of active natural products and optimization of drug properties; drug synthesis of synthetic methods and other advantages. Research Orientation: Molecular Design and Synthesis of New Drugs
Publications
-
Naugle JE, Olson ER, Zhang X, Mase SE, Pilati CF, Maron MB, Folkesson HG, Horne WI, Doane KJ, Meszaros JG. Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. American Journal of Physiology-Heart and Circulatory Physiology. 2006 Jan 1;290(1):H323-30.
-
Olson ER, Naugle JE, Zhang X, Bomser JA, Meszaros JG. Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol. American Journal of Physiology-Heart and Circulatory Physiology. 2005 Mar 1;288(3):H1131-8.
